SS Innovations Files 10-Q Amendment

Ticker: SSII · Form: 10-Q/A · Filed: Feb 19, 2025 · CIK: 1676163

Sentiment: neutral

Topics: 10-Q, amendment, financial-reporting

TL;DR

SS Innovations filed a 10-Q amendment for Q1 2024. Check for updates.

AI Summary

SS Innovations International, Inc. filed an Amendment No. 1 to its Form 10-Q on February 19, 2025, for the quarterly period ended March 31, 2024. The company, formerly known as AVRA Medical Robotics, Inc., is incorporated in Florida and operates in the Surgical & Medical Instruments & Apparatus industry. Its principal executive offices are located in Gurugram, Haryana, India.

Why It Matters

This filing indicates an update or correction to the company's quarterly financial reporting, which is crucial for investors to assess the company's performance and financial health.

Risk Assessment

Risk Level: medium — Amendments to SEC filings can sometimes indicate previously undisclosed issues or corrections that may impact investor perception.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 10-Q/A filing?

This filing is Amendment No. 1 to the Form 10-Q for the quarterly period ended March 31, 2024, indicating an update or correction to the original filing.

When was this amendment filed?

The amendment was filed on February 19, 2025.

What was the previous name of SS Innovations International, Inc.?

The company was formerly known as AVRA Medical Robotics, Inc.

Where are SS Innovations International, Inc.'s principal executive offices located?

The principal executive offices are located at 405, 3rd Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana, 122016, India.

What industry does SS Innovations International, Inc. operate in?

The company operates in the Surgical & Medical Instruments & Apparatus industry, with SIC code 3841.

Filing Details

This Form 10-Q/A (Form 10-Q/A) was filed with the SEC on February 19, 2025 regarding SS Innovations International, Inc. (SSII).

View full filing on EDGAR

View Full Filing

View this 10-Q/A filing on SEC EDGAR

View on Read The Filing